3 Best Biotech Stocks During Trump's First 100 Days

3 Best Biotech Stocks During Trump's First 100 Days


Big catalysts at Esperion Therapeutics, Aurinia Pharmaceuticals, and TG Therapeutics have resulted in eye-popping returns during the first 100 days of Donald Trump's presidency. Donald Trump won the U.S. presidency on promises to lower drug prices.



from Biotech News